Securities

Semler Scientific Inc. Securities Lawsuit Investigation

Meta Description: If you purchased or held Semler Scientific Inc. securities between May 05, 2020, and May 20, 2025, you may be eligible to join a securities investigation and seek compensation for
Updated on
Published on
Semler Scientific Inc. Securities Lawsuit Investigation
Semler Scientific Inc. Securities Lawsuit Investigation

Shamis & Gentile P.A., one of the nation's premier class action law firms specializing in securities fraud cases, is investigating potential claims against Semler Scientific Inc. (SMLR).

If you purchased or held Semler Scientific Inc. securities between May 20, 2020 and May 20, 2025, you may be eligible to join this securities investigation and seek compensation for your losses.

About Semler Scientific Inc.

Semler Scientific Inc. is a medical technology company, best known for its QuantaFlo product, which is used for the early detection of peripheral arterial disease. The company operates in the healthcare diagnostics sector and has historically generated revenue through sales and licensing of its proprietary medical devices to healthcare providers.

In recent years, Semler Scientific has attracted attention due to its strategic decisions and financial maneuvers. Most notably, the company made headlines in 2024 and 2025 after announcing a significant shift in its treasury strategy, including the acquisition of substantial Bitcoin holdings. This move, along with other financial decisions, has contributed to increased scrutiny from investors and regulators.

The Allegations

The investigation centers on whether Semler Scientific misled investors about several key issues. First, there are concerns regarding the company’s abrupt pivot to a Bitcoin treasury strategy. Investors allege that this move was not adequately disclosed or explained, creating uncertainty about the company’s financial stability and long-term strategy.

Additionally, there are allegations that Semler Scientific downplayed or failed to properly disclose the dilution risks associated with its convertible notes and equity offerings. These financial instruments can impact shareholder value, and insufficient transparency may have left investors unaware of potential risks.

Another significant point of concern is the impact of a Department of Justice (DOJ) False Claims Act settlement related to the QuantaFlo product. The settlement raised questions about the company’s compliance practices and potential financial liabilities. When corrective disclosures about these issues were made, Semler Scientific’s stock price experienced major declines, prompting further shareholder investigations.

Proposed Class Period

The proposed class period for this investigation is from May 20, 2020 to May 20, 2025. It is important to note that this is a proposed timeframe and may change as the investigation progresses.

The class period is significant because it defines the window during which investors may have been affected by the alleged misconduct. If you purchased or held SMLR securities during this time, you may be eligible to participate in any future class action that results from this investigation.

Your Rights and Next Steps

As an investor, you have the right to know whether your financial losses were caused by misleading statements or omissions by Semler Scientific. Since this is an ongoing investigation and not yet a filed lawsuit, no class action has been certified at this time. However, if sufficient evidence is uncovered, a class action lawsuit may be filed on behalf of affected investors.

Lawyers are ready to help you understand your options and guide you through the process. You can participate in the investigation by submitting your information, which helps ensure you are notified about any developments, including the potential filing of a lawsuit or settlement opportunities.

Taking action now is important. By joining the investigation, you preserve your rights and stay informed about any compensation that may become available if a class action is filed.

You May Be Entitled to Compensation

If you purchased or held Semler Scientific Inc. securities during the proposed class period, you may be entitled to compensation for your losses. Securities investigations are time-sensitive, and your eligibility to join any potential class action may depend on when you take action.

To protect your rights and maximize your potential recovery, complete the below form to join the investigation. Lawyers are ready to help answer your questions and keep you updated on the progress of the case.

Submit Your Claim